SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Return on equity
5Y CAGR
-29.8%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.76% | +106.7% |
| 2024 | -131.33% | -78.3% |
| 2023 | -73.64% | -22.0% |
| 2022 | -60.34% | -35.7% |
| 2021 | -44.47% | -186.2% |
| 2020 | 51.57% | -86.8% |
| 2019 | 389.75% | - |